scispace - formally typeset
Open AccessJournal ArticleDOI

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

TLDR
Authors/Task Force Members (François Macha, Colin Baigentb,∗∗,2, Alberico L. Catapanoc), ESC Committee for Practice Guidelines (CPG) (Stephan Windeckeraa), ESC National Cardiac Societies (Djamaleddine Nibouchean, Parounak H. Patelcl)
About
This article is published in Atherosclerosis.The article was published on 2019-09-02 and is currently open access. It has received 2972 citations till now. The article focuses on the topics: Lipid modification & Very low-density lipoprotein.

read more

Citations
More filters
Journal ArticleDOI

The Long-Term Dietitian and Psychological Support of Obese Patients Who Have Reduced Their Weight Allows Them to Maintain the Effects.

TL;DR: In this article, a randomized controlled study was conducted to explore the efficacy of following dietary and psychological support in a group of 36 obese individuals, which included some elements of Ten Top Tips (TTT), cognitive behavioral therapy (CBT), motivational interviewing (MI), nutritional education and assessment of the level of physical activity.
Journal ArticleDOI

Low-density lipoprotein particles in atherosclerosis

TL;DR: The atherogenic mechanisms of action of LDL are outlined by focusing on sdLDL and ox-LDL, the methods used for measurement of LDL subclasses are summarized, and advances in LDL-lowering therapies using statins and PCSK9i are concluded.
Journal ArticleDOI

Low LDL-C levels are associated with risk of mortality in a Chinese cohort study

TL;DR: In this article, the association of LDL-C level with risk of mortality using a propensity-score weighting method in a Chinese population, based on the health examination data was examined, and the authors used Cox proportional hazard regression models with all-cause and cause-specific mortality as the dependent variables to estimate hazard ratios and 95% confidence intervals.
Journal ArticleDOI

Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials

TL;DR: Both alirocumab and evolocumab are well tolerated and can greatly improve lipid profiles for patients at high cardiovascular risk and significantly reduce the risk of nonfatal MACEs in patients with previous cardiovascular events.
References
More filters
Journal ArticleDOI

Atherosclerosis — An Inflammatory Disease

TL;DR: Atherosclerosis is an inflammatory disease as discussed by the authors, and it is a major cause of death in the United States, Europe, and much of Asia, despite changes in lifestyle and use of new pharmacologic approaches to lower plasma cholesterol concentrations.
Journal ArticleDOI

2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Giuseppe Mancia, +89 more
TL;DR: In this article, a randomized controlled trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly people was presented. But the authors did not discuss the effect of the combination therapy in patients living with systolic hypertension.
Journal Article

Atherosclerosis is an Inflammatory Disease

TL;DR: Despite changes in lifestyle and the use of new pharmacologic approaches to lower plasma cholesterol concentrations, cardiovascular disease continues to be the principal cause of death in the United States, Europe, and much of Asia.

Standards of Medical Care in Diabetes

TL;DR: These standards of care are intended to provide clinicians, patients, researchers, payors, and other interested individuals with the components of diabetes care, treatment goals, and tools to evaluate the quality of care.
Related Papers (5)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

François Mach, +120 more